Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
07 2020
Historique:
received: 09 10 2019
accepted: 23 03 2020
pubmed: 17 6 2020
medline: 25 2 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

Genetic mutations in Using mass spectrometry, we found that ACTN4 is phosphorylated at serine (S) 159 in human podocytes. We used phosphomimetic and nonphosphorylatable ACTN4 to comprehensively study the effects of this phosphorylation Compared with the wild type ACTN4, phosphomimetic ACTN4 demonstrated increased binding and bundling activity with F-actin These findings suggest that increased phosphorylation of ACTN4 at S159 leads to biochemical, cellular, and renal pathology that is similar to pathology resulting from human disease-causing mutations in ACTN4. ACTN4 may mediate podocyte injury as a consequence of both genetic mutations and signaling events that modulate phosphorylation.

Sections du résumé

BACKGROUND
Genetic mutations in
METHODS
Using mass spectrometry, we found that ACTN4 is phosphorylated at serine (S) 159 in human podocytes. We used phosphomimetic and nonphosphorylatable ACTN4 to comprehensively study the effects of this phosphorylation
RESULTS
Compared with the wild type ACTN4, phosphomimetic ACTN4 demonstrated increased binding and bundling activity with F-actin
CONCLUSIONS
These findings suggest that increased phosphorylation of ACTN4 at S159 leads to biochemical, cellular, and renal pathology that is similar to pathology resulting from human disease-causing mutations in ACTN4. ACTN4 may mediate podocyte injury as a consequence of both genetic mutations and signaling events that modulate phosphorylation.

Identifiants

pubmed: 32540856
pii: ASN.2019101032
doi: 10.1681/ASN.2019101032
pmc: PMC7351002
doi:

Substances chimiques

ACTN4 protein, human 0
Actins 0
Actn4 protein, mouse 0
Peptidomimetics 0
Transforming Growth Factor beta 0
Actinin 11003-00-2
Serine 452VLY9402
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1479-1495

Subventions

Organisme : NIDDK NIH HHS
ID : K01 DK114329
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034854
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK059588
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007199
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK096493
Pays : United States

Informations de copyright

Copyright © 2020 by the American Society of Nephrology.

Références

Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5
pubmed: 20057045
Am J Physiol Renal Physiol. 2008 Oct;295(4):F959-70
pubmed: 18684887
Nat Rev Nephrol. 2015 Feb;11(2):76-87
pubmed: 25447132
J Am Soc Nephrol. 2014 Sep;25(9):1991-2002
pubmed: 24676636
J Clin Invest. 2015 Jun;125(6):2375-84
pubmed: 25961457
Protein Sci. 2018 Jan;27(1):112-128
pubmed: 28836357
N Engl J Med. 2011 Jul 28;365(4):295-306
pubmed: 21756023
Mol Cell Proteomics. 2012 Dec;11(12):1709-23
pubmed: 22962056
PLoS One. 2016 Dec 15;11(12):e0167467
pubmed: 27977723
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1517-1522
pubmed: 29378953
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16080-5
pubmed: 17901210
Am J Physiol Renal Physiol. 2013 Feb 15;304(4):F333-47
pubmed: 23235479
J Hypertens. 2005 Oct;23(10):1895-903
pubmed: 16148614
Exp Cell Res. 1997 Oct 10;236(1):248-58
pubmed: 9344605
Nat Genet. 2010 Jan;42(1):72-6
pubmed: 20023659
J Biol Chem. 2010 Jan 22;285(4):2591-600
pubmed: 19920151
Front Biosci (Landmark Ed). 2009 Jan 01;14(7):2448-65
pubmed: 19273211
J Am Soc Nephrol. 2005 May;16(5):1223-35
pubmed: 15829713
J Cell Physiol. 2009 Nov;221(2):288-95
pubmed: 19562677
J Am Soc Nephrol. 2017 Nov;28(11):3166-3174
pubmed: 28864466
Exp Cell Res. 2013 May 1;319(8):1124-35
pubmed: 23454549
J Vis Exp. 2018 Oct 20;(140):
pubmed: 30394380
Am J Hum Genet. 2013 Mar 7;92(3):431-8
pubmed: 23434115
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Sci Signal. 2015 May 26;8(378):ra51
pubmed: 26012634
Nat Commun. 2015 Jun 25;6:7525
pubmed: 26109233
J Am Soc Nephrol. 2002 Mar;13(3):630-638
pubmed: 11856766
Kidney Int. 2008 Mar;73(6):741-50
pubmed: 18185509
Nucleic Acids Res. 2012 Jan;40(Database issue):D261-70
pubmed: 22135298
Nat Genet. 2000 Mar;24(3):251-6
pubmed: 10700177
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Adv Anat Embryol Cell Biol. 2016;219:69-93
pubmed: 27207363
Am J Physiol Renal Physiol. 2018 May 1;314(5):F921-F925
pubmed: 29363327
J Mol Biol. 1963 Jul;7:95-9
pubmed: 13990617
Am J Hum Genet. 2001 Nov;69(5):1033-45
pubmed: 11590545
J Mol Biol. 2008 Feb 15;376(2):317-24
pubmed: 18164029
Nat Neurosci. 2011 Jun;14(6):727-35
pubmed: 21516102
J Clin Invest. 2011 Oct;121(10):4127-37
pubmed: 21911940
Methods Mol Biol. 2012;933:17-29
pubmed: 22893398
Nephrol Dial Transplant. 2014 Jan;29(1):65-72
pubmed: 24166460
J Diabetes Res. 2015;2015:697010
pubmed: 26064987
Proteomics. 2016 Aug;16(15-16):2146-59
pubmed: 27145088
Curr Protoc Hum Genet. 2007 Jul;Chapter 17:Unit 17.3
pubmed: 18428409
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Protein Sci. 2003 Sep;12(9):1865-71
pubmed: 12930986
J Am Soc Nephrol. 2005 Dec;16(12):3694-701
pubmed: 16251236
Mol Cell Proteomics. 2018 Feb;17(2):384-396
pubmed: 29192002
Kidney Int. 1992 Jul;42(1):148-60
pubmed: 1635344
Am J Physiol Renal Physiol. 2015 Mar 15;308(6):F588-93
pubmed: 25587117
J Med Genet. 2013 May;50(5):330-8
pubmed: 23434736
J Am Soc Nephrol. 2015 Feb;26(2):258-69
pubmed: 25060060
Nat Protoc. 2006;1(6):2856-60
pubmed: 17406544
PLoS Biol. 2004 Jun;2(6):e167
pubmed: 15208719
Nat Rev Nephrol. 2011 Oct 25;8(1):14-21
pubmed: 22025085
Adv Chronic Kidney Dis. 2014 Sep;21(5):408-16
pubmed: 25168829
Nat Genet. 1999 Apr;21(4):353-4
pubmed: 10192379
J Mol Biol. 2011 Sep 2;411(5):1062-71
pubmed: 21762701
Cell Biosci. 2015 Aug 18;5:44
pubmed: 26301083
BMC Nephrol. 2015 Jul 09;16:101
pubmed: 26156092
Kidney Int. 2007 Nov;72(10):1226-32
pubmed: 17851470
J Am Coll Cardiol. 2010 Mar 16;55(11):1127-35
pubmed: 20022194
EMBO J. 2014 Feb 18;33(4):385-99
pubmed: 24510915
Nat Struct Mol Biol. 2010 May;17(5):614-6
pubmed: 20383143

Auteurs

Di Feng (D)

Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts dfeng@bidmc.harvard.edu mpollak@bidmc.harvard.edu.
Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.

Mukesh Kumar (M)

Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
F.M. Kirby Neurobiology Center, Department of Neurobiology, Boston Children's Hospital, Boston, Massachusetts.

Jan Muntel (J)

Biognosys AG, Schlieren, Switzerland.

Susan B Gurley (SB)

Division of Nephrology and Hypertension, Oregon Health & Science University, Portland, Oregon.

Gabriel Birrane (G)

Division of Experimental Medicine, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

Isaac E Stillman (IE)

Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

Lai Ding (L)

NeuroTechnology Studio, Program for Interdisciplinary Neuroscience, Brigham and Women's Hospital, Boston, Massachusetts.

Minxian Wang (M)

Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.

Saima Ahmed (S)

Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.

Johannes Schlondorff (J)

Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

Seth L Alper (SL)

Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.

Tom Ferrante (T)

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.

Susan L Marquez (SL)

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.

Carlos F Ng (CF)

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts dfeng@bidmc.harvard.edu mpollak@bidmc.harvard.edu.

Richard Novak (R)

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.

Donald E Ingber (DE)

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.
Vascular Biology Program, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, Massachusetts.

Hanno Steen (H)

Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.

Martin R Pollak (MR)

Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts dfeng@bidmc.harvard.edu mpollak@bidmc.harvard.edu.
Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH